Picornaviridae Infections  >>  Locteron (interferon alpha-2b CR)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Locteron (interferon alpha-2b CR) / Biolex
480S, NCT00953589 / 2009-011182-86: 480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)

Completed
2b
74
Europe, RoW
ribavirin, Ribasphere
Biolex Therapeutics, Inc.
Hepatitis C, Chronic
05/10
01/11
PLUS, NCT00593151: Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C

Completed
1/2
32
US
Locteron (controlled-release interferon alpha 2b), PolyActive-IFNa2b, BLX-883+PolyActive, pegylated IFNa2b, PEG-Intron, PEG, 12 kDalton pegylated interferon alpha 2b
Biolex Therapeutics, Inc.
Hepatitis C
12/08
03/09

Download Options